MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover the role of genetic testing in hydrochlorothiazide response for high blood pressure & fluid retention treatment, and how it personalizes patient care.
Uncoupled oxidative phosphorylation raises energy use, causing poor weight gain, fatigue and developmental delay. Carrier, prenatal and newborn testing follow.
Fibroblast growth factor 8, encoded by FGF8, shapes the reproductive and olfactory systems alike, and mutations leave puberty absent in HH15.
Discover the importance of genetic testing in diagnosing and managing Hypokinetic Non-Dilated Cardiomyopathy (HNDC) for patients and their families. Learn how it guides treatment…
Ring-shaped patches of scaly, inflamed skin follow KRT10 mutations that weaken keratin 10; skin biopsy and DNA testing confirm AEI-2 and flag at-risk relatives.
Overactive PI3K-delta, the result of PIK3CD mutations, weakens immunity and drives lymphocyte overgrowth; flow cytometry, biopsy and DNA testing confirm the diagnosis.
Discover the importance of diagnosing X-Linked Hyper-IgM Syndrome, its symptoms, and how genetic testing plays a crucial role in managing this rare immunodeficiency disorder.
Up to 40% of IDD cases are thought to have a genetic cause, and DNA analysis alongside developmental assessment can shape support needs and early intervention.